In our study, median values of Il-6 and CRP were, respectively, 16.76 pg/mL (range: 0.5–79.75) and 75.02 mg/L (range: 1–243) for patients with ovarian cancer and 5.92 pg/mL (range: 0.5–40.19) vs. 26 mg/L (range: 1–330) for women with a benign pelvic tumor. The gene discussed is IL6; the disease is ovarian cancer.